Betteromics
PrivateLast Round
Series A
Oct 26, 2023
Total Funding Raised
$40M
Company Overview
Betteromics is a life sciences software company that provides an AI-driven cloud platform for integrating, analyzing, and visualizing multi-modal multi-omics data to accelerate drug development and clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Data Integration, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Betteromics Comparables
Compare Betteromics with similar companies based on industry and business-model similarity.
Betteromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 26, 2023 | ||||
| Series A | Oct 26, 2023 |
Betteromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Triatomic Capital | Seed, Series A |
| Plum Alley Investments | Series A |
| Sofinnova Partners | Series A |
| Shakti Ventures | Series A |
| Decheng Capital | Series A |
| Life Extension Ventures | Series A |
| Unusual Ventures | Series A |
Betteromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Betteromics's valuation, stock price, and market status.